NEWS & EVENTS | OSLO UNIVERSITETSSYKEHUS - HOSPITAL PAGES IN NORWEGIAN

Publications

Publications published since 2000 or in press from OUS - Department of Immunology Inst Cancer Res

319 publications found

Publications in press

  1. Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J
    T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells
    Int J Cancer (in press)
    PubMed 21630262
  2. Mobergslien A, Sioud M
    Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-? production
    J Leukoc Biol (in press)
    PubMed 22167721
  3. Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, Maelandsmo GM, Fodstad O
    B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
    Int J Cancer (in press)
    PubMed 21671471

Publications 2012

  1. Adamczak M, Hoel HJ, Gaudernack G, Barbasz J, Szczepanowicz K, Warszy?ski P (2012)
    Polyelectrolyte multilayer capsules with quantum dots for biomedical applications
    Colloids Surf B Biointerfaces, 90, 211-6
    PubMed 22078925
  2. Béziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, Hervier B, Theodorou I, Martinot M, Debré P, Björkström NK, Malmberg KJ, Marcellin P, Vieillard V (2012)
    CMV drives clonal expansion of NKG2C(+) NK cells expressing self-specific KIRs in chronic hepatitis patients
    Eur J Immunol, 42 (2), 447-57
    PubMed 22105371
  3. Kersten C, Cameron MG, Oldenburg J (2012)
    Truth in hope and hope in truth
    J Palliat Med, 15 (1), 128-9
    PubMed 22268412
  4. Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, Sundström C, Christensson B, Sander B (2012)
    Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times
    Br J Haematol, 156 (2), 225-33
    PubMed 22126847

Publications 2011

  1. Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH, Gascoyne RD, Briones J, Tibshirani RJ, Myklebust JH, Plevritis SK, Lossos IS, Levy R (2011)
    Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
    Blood, 118 (5), 1350-8
    PubMed 21670469
  2. Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM (2011)
    Transiently redirected T cells for adoptive transfer
    Cytotherapy, 13 (5), 629-40
    PubMed 21174490
  3. Brunsvig PF, Kyte JA, Kersten C, Sundstrøm S, Møller M, Nyakas M, Hansen GL, Gaudernack G, Aamdal S (2011)
    Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial
    Clin Cancer Res, 17 (21), 6847-57
    PubMed 21918169
  4. Cameron MG, Kersten C, van Helvoirt R, Rohde G, Fosså SD, Vistad I (2011)
    Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study
    BMC Res Notes, 4, 252
    PubMed 21777440
  5. Eide MB, Lauritzsen GF, Kvalheim G, Kolstad A, Fagerli UM, Maisenhölder M, Østenstad B, Fluge Ø, Delabie J, Aarset H, Liestøl K, Holte H (2011)
    High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
    Br J Haematol, 152 (5), 600-10
    PubMed 21241276
  6. Hunger RE, Kernland Lang K, Markowski CJ, Trachsel S, Møller M, Eriksen JA, Rasmussen AM, Braathen LR, Gaudernack G (2011)
    Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
    Cancer Immunol Immunother, 60 (11), 1553-64
    PubMed 21681371
  7. Huse K, Bakkebø M, Oksvold MP, Forfang L, Hilden VI, Stokke T, Smeland EB, Myklebust JH (2011)
    Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7
    Eur J Immunol, 41 (11), 3135-45
    PubMed 21898381
  8. Josefsen D, Forfang L, Dyrhaug M, Blystad AK, Stokke T, Smeland EB, Kvalheim G (2011)
    Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy
    Eur J Haematol, 87 (6), 494-502
    PubMed 21752097
  9. Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S (2011)
    Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients
    Clin Cancer Res, 17 (13), 4568-80
    PubMed 21586625
  10. Malumbres R, Fresquet V, Roman-Gomez J, Bobadilla M, Robles EF, Altobelli GG, Calasanz MJ, Smeland EB, Aznar MA, Agirre X, Martin-Palanco V, Prosper F, Lossos IS, Martinez-Climent JA (2011)
    LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome
    Haematologica, 96 (7), 980-6
    PubMed 21459790
  11. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI et al. (2011)
    Oncogenically active MYD88 mutations in human lymphoma
    Nature, 470 (7332), 115-9
    PubMed 21179087
  12. Sioud M (2011)
    Promises and challenges in developing RNAi as a research tool and therapy
    Methods Mol Biol, 703, 173-87
    PubMed 21125490
  13. Sioud M (2011)
    New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins
    Scand J Immunol, 73 (2), 79-84
    PubMed 21198747
  14. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2011)
    Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
    Int J Oncol, 38 (2), 385-90
    PubMed 21165555
  15. Soko?owska I, Wälchli S, W?grzyn G, Sandvig K, S?omi?ska-Wojewódzka M (2011)
    A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation
    Biochem J, 436 (2), 371-85
    PubMed 21388347
  16. Stratmann J, Wang CJ, Gnosa S, Wallin A, Hinselwood D, Sun XF, Zhang H (2011)
    Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients
    BMC Cancer, 11, 345
    PubMed 21827717
  17. Suso EM, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, Gaudernack G (2011)
    hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
    Cancer Immunol Immunother, 60 (6), 809-18
    PubMed 21365467
  18. Tkacz-Stachowska K, Lund-Andersen C, Velissarou A, Myklebust JH, Stokke T, Syljuåsen RG (2011)
    The amount of DNA damage needed to activate the radiation-induced G2 checkpoint varies between single cells
    Radiother Oncol, 101 (1), 24-7
    PubMed 21722983
  19. Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
    The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
    Scand J Immunol, 74 (6), 632-9
    PubMed 21883353
  20. Wedén S, Klemp M, Gladhaug IP, Møller M, Eriksen JA, Gaudernack G, Buanes T (2011)
    Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
    Int J Cancer, 128 (5), 1120-8
    PubMed 20473937
  21. Wälchli S, Løset GÅ, Kumari S, Johansen JN, Yang W, Sandlie I, Olweus J (2011)
    A practical approach to T-cell receptor cloning and expression
    PLoS One, 6 (11), e27930
    PubMed 22132171

Publications 2010

  1. Abraham D, Zins K, Sioud M, Lucas T, Schäfer R, Stanley ER, Aharinejad S (2010)
    Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma
    Int J Cancer, 126 (6), 1339-52
    PubMed 19711348
  2. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
    Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
    Leukemia, 24 (11), 1901-9
    PubMed 20844564
  3. Almåsbak H, Lundby M, Rasmussen AM (2010)
    Non-MHC-dependent redirected T cells against tumor cells
    Methods Mol Biol, 629, 453-93
    PubMed 20387166
  4. Bakkebø M, Huse K, Hilden VI, Smeland EB, Oksvold MP (2010)
    TGF-?-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK
    BMC Immunol, 11, 57
    PubMed 21092277
  5. Ben-Mahrez K, Sioud M (2010)
    Presence of STRA-STRB linked streptomycin-resistance genes in clinical isolate of Escherichia coil 2418
    Arch Inst Pasteur Tunis, 87 (1-2), 77-81
    PubMed 21598829
  6. Bøe S, Saebøe-Larssen S, Hovig E (2010)
    Light-induced gene expression using messenger RNA molecules
    Oligonucleotides, 20 (1), 1-6
    PubMed 20038251
  7. Cekaite L, Clancy T, Sioud M (2010)
    Increased miR-21 expression during human monocyte differentiation into DCs
    Front Biosci (Elite Ed), 2, 818-28
    PubMed 20515755
  8. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R (2010)
    Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
    Cell, 142 (5), 699-713
    PubMed 20813259
  9. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E et al. (2010)
    Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
    Nature, 463 (7277), 88-92
    PubMed 20054396
  10. Eide MB, Liestøl K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J (2010)
    Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones
    Blood, 116 (9), 1489-97
    PubMed 20505157
  11. Fløisand Y, Sioud M (2010)
    Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications
    Methods Mol Biol, 629, 507-23
    PubMed 20387168
  12. Fredriksen L, Mathiesen G, Sioud M, Eijsink VG (2010)
    Cell wall anchoring of the 37-kilodalton oncofetal antigen by Lactobacillus plantarum for mucosal cancer vaccine delivery
    Appl Environ Microbiol, 76 (21), 7359-62
    PubMed 20851975
  13. Groth M, Wiegand C, Szafranski K, Huse K, Kramer M, Rosenstiel P, Schreiber S, Norgauer J, Platzer M (2010)
    Both copy number and sequence variations affect expression of human DEFB4
    Genes Immun, 11 (6), 458-66
    PubMed 20445567
  14. Irish JM, Myklebust JH, Alizadeh AA, Houot R, Sharman JP, Czerwinski DK, Nolan GP, Levy R (2010)
    B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression
    Proc Natl Acad Sci U S A, 107 (29), 12747-54
    PubMed 20543139
  15. Iversen PO, Sørensen DR, Sioud M (2010)
    A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
    Thromb Haemost, 104 (2), 350-4
    PubMed 20539915
  16. Kyte JA (2010)
    Third International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD 2009)
    Expert Rev Vaccines, 9 (2), 119-23
    PubMed 20109021
  17. Kyte JA (2010)
    [We know more than we can understand]
    Tidsskr Nor Laegeforen, 130 (22), 2217
    PubMed 21109831
  18. Mobergslien A, Sioud M (2010)
    Optimized protocols for siRNA delivery into monocytes and dendritic cells
    Methods Mol Biol, 629, 71-85
    PubMed 20387143
  19. Rasmussen AM, Borelli G, Hoel HJ, Lislerud K, Gaudernack G, Kvalheim G, Aarvak T (2010)
    Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
    J Immunol Methods, 355 (1-2), 52-60
    PubMed 20171968
  20. Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Möller P, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM et al. (2010)
    Cooperative epigenetic modulation by cancer amplicon genes
    Cancer Cell, 18 (6), 590-605
    PubMed 21156283
  21. Sanner H, Kirkhus E, Merckoll E, Tollisen A, Røisland M, Lie BA, Taraldsrud E, Gran JT, Flatø B (2010)
    Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study
    Arthritis Care Res (Hoboken), 62 (8), 1103-11
    PubMed 20506141
  22. Sioud M (2010)
    Modulation of dendritic cell maturation and function by siRNA-bearing 5'-triphosphate
    Methods Mol Biol, 629, 395-404
    PubMed 20387164
  23. Sioud M (2010)
    Recent advances in small interfering RNA sensing by the immune system
    N Biotechnol, 27 (3), 236-42
    PubMed 20219711
  24. Sioud M (2010)
    What are the key targeted delivery technologies of siRNA now?
    Methods Mol Biol, 629, 93-107
    PubMed 20387145
  25. Sioud M (2010)
    Overcoming self-tolerance to tumour cells
    Methods Mol Biol, 629, 495-505
    PubMed 20387167
  26. Sioud M (2010)
    Advances in RNA sensing by the immune system: separation of siRNA unwanted effects from RNA interference
    Methods Mol Biol, 629, 33-52
    PubMed 20387141
  27. Sioud M (2010)
    Development of TLR7/8 small RNA antagonists
    Methods Mol Biol, 629, 387-94
    PubMed 20387163
  28. Sioud M (2010)
    RNA therapeutics: function, design, and delivery. Preface
    Methods Mol Biol, 629, v-vii
    PubMed 20394129
  29. Sioud M, Cekaite L (2010)
    Profiling of miRNA expression and prediction of target genes
    Methods Mol Biol, 629, 257-71
    PubMed 20387154
  30. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
    Scand J Immunol, 71 (4), 267-74
    PubMed 20384870
  31. Smeland EB, Vartdal F, Wisløff F (2010)
    [Close cooperation, but not oversteering]
    Tidsskr Nor Laegeforen, 130 (6), 590-1
    PubMed 20348990
  32. Smeland EB, Vartdal F, Wisløff F (2010)
    [Leadership and academic competence]
    Tidsskr Nor Laegeforen, 130 (6), 591
    PubMed 20348994
  33. Szczepanowicz K, Hoel HJ, Szyk-Warszynska L, Biela?ska E, Bouzga AM, Gaudernack G, Simon C, Warszynski P (2010)
    Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorption
    Langmuir, 26 (15), 12592-7
    PubMed 20604580
  34. Sørensen DR, Sioud M (2010)
    Systemic delivery of synthetic siRNAs
    Methods Mol Biol, 629, 87-91
    PubMed 20387144
  35. Yamazaki T, Wälchli S, Fujita T, Ryser S, Hoshijima M, Schlegel W, Kuroda S, Maturana AD (2010)
    Splice variants of enigma homolog, differentially expressed during heart development, promote or prevent hypertrophy
    Cardiovasc Res, 86 (3), 374-82
    PubMed 20097676

Publications 2009

  1. Aharinejad S, Sioud M, Lucas T, Abraham D (2009)
    Targeting stromal-cancer cell interactions with siRNAs
    Methods Mol Biol, 487, 243-66
    PubMed 19301651
  2. Cekaite L, Hovig E, Sioud M (2009)
    Monitoring B cell response to immunoselected phage-displayed peptides by microarrays
    Methods Mol Biol, 524, 273-85
    PubMed 19377952
  3. Copier J, Dalgleish AG, Britten CM, Finke LH, Gaudernack G, Gnjatic S, Kallen K, Kiessling R, Schuessler-Lenz M, Singh H, Talmadge J, Zwierzina H, Håkansson L (2009)
    Improving the efficacy of cancer immunotherapy
    Eur J Cancer, 45 (8), 1424-31
    PubMed 19167214
  4. Flatekval GF, Sioud M (2009)
    Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase
    Immunology, 128 (1 Suppl), e837-48
    PubMed 19740345
  5. Gao Q, Geng L, Kvalheim G, Gaudernack G, Suo Z (2009)
    Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3
    Ultrastruct Pathol, 33 (4), 175-81
    PubMed 19728235
  6. Gran JT, Molberg Ø, Dobloug GC, Andersson H, Taraldsrud E, Scheie D (2009)
    [Myositis-specific autoantibodies]
    Tidsskr Nor Laegeforen, 129 (16), 1631-4
    PubMed 19721478
  7. Hauge H, Fjelland KE, Sioud M, Aasheim HC (2009)
    Evidence for the involvement of FAM110C protein in cell spreading and migration
    Cell Signal, 21 (12), 1866-73
    PubMed 19698782
  8. Holte H, Kvaløy S, Delabie J, Trøen G, Smeland EB (2009)
    [Molecular diagnosis of malignant lymphomas]
    Tidsskr Nor Laegeforen, 129 (22), 2352-6
    PubMed 19935935
  9. Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R (2009)
    Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
    Blood, 114 (16), 3431-8
    PubMed 19641184
  10. Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
    Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
    Transl Oncol, 2 (4), 242-6
    PubMed 19956385
  11. Kyte JA (2009)
    Cancer vaccination with telomerase peptide GV1001
    Expert Opin Investig Drugs, 18 (5), 687-94
    PubMed 19388882
  12. Kyte JA (2009)
    [Nobel Prize for mitotic clock]
    Tidsskr Nor Laegeforen, 129 (23), 2470
    PubMed 19997132
  13. Kyte JA, Trachsel S, Risberg B, thor Straten P, Lislerud K, Gaudernack G (2009)
    Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination
    Cancer Immunol Immunother, 58 (10), 1609-26
    PubMed 19221745
  14. Nygren MK, Døsen-Dahl G, Stubberud H, Wälchli S, Munthe E, Rian E (2009)
    beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells
    Exp Hematol, 37 (2), 225-33
    PubMed 19101069
  15. O'Riain C, O'Shea DM, Yang Y, Le Dieu R, Gribben JG, Summers K, Yeboah-Afari J, Bhaw-Rosun L, Fleischmann C, Mein CA, Crook T, Smith P, Kelly G, Rosenwald A, Ott G, Campo E, Rimsza LM, Smeland EB, Chan WC, Johnson N, Gascoyne RD, Reimer S, Braziel RM, Wright GW, Staudt LM et al. (2009)
    Array-based DNA methylation profiling in follicular lymphoma
    Leukemia, 23 (10), 1858-66
    PubMed 19587707
  16. Rölle A, Olweus J (2009)
    Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures
    APMIS, 117 (5-6), 413-26
    PubMed 19400865
  17. Sioud M (2009)
    Deciphering the code of innate immunity recognition of siRNAs
    Methods Mol Biol, 487, 41-59
    PubMed 19301641
  18. Sioud M (2009)
    Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells
    Methods Mol Biol, 487, 61-82
    PubMed 19301642
  19. Sioud M (2009)
    Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?
    Scand J Immunol, 70 (6), 516-25
    PubMed 19906192
  20. Sioud M, Boudabous A, Cekaite L (2009)
    Transcriptional responses of Bacillus subtillis and thuringiensis to antibiotics and anti-tumour drugs
    Int J Mol Med, 23 (1), 33-9
    PubMed 19082504
  21. Sioud M, Fløisand Y (2009)
    NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation
    J Leukoc Biol, 85 (6), 939-46
    PubMed 19244164
  22. Skånland SS, Wälchli S, Brech A, Sandvig K (2009)
    SNX4 in complex with clathrin and dynein: implications for endosome movement
    PLoS One, 4 (6), e5935
    PubMed 19529763
  23. Skånland SS, Wälchli S, Sandvig K (2009)
    ?-arrestins attenuate p38-mediated endosome to Golgi transport
    Cell Microbiol, 11 (5), 796-807
    PubMed 19159388
  24. Stolp HB, Ek CJ, Johansson PA, Dziegielewska KM, Bethge N, Wheaton BJ, Potter AM, Saunders NR (2009)
    Factors involved in inflammation-induced developmental white matter damage
    Neurosci Lett, 451 (3), 232-6
    PubMed 19152829
  25. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
    Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
    Scand J Immunol, 69 (4), 319-28
    PubMed 19284496
  26. Wälchli S, Aasheim HC, Skånland SS, Spilsberg B, Torgersen ML, Rosendal KR, Sandvig K (2009)
    Characterization of clathrin and Syk interaction upon Shiga toxin binding
    Cell Signal, 21 (7), 1161-8
    PubMed 19289168

Publications 2008

  1. Abraham D, Zins K, Sioud M, Lucas T, Aharinejad S (2008)
    Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts
    Front Biosci, 13, 5571-9
    PubMed 18508606
  2. Alsøe L, Stacy JE, Fosså A, Funderud S, Brekke OH, Gaudernack G (2008)
    Identification of prostate cancer antigens by automated high-throughput filter immunoscreening
    J Immunol Methods, 330 (1-2), 12-23
    PubMed 18045611
  3. Chekenya M, Krakstad C, Svendsen A, Netland IA, Staalesen V, Tysnes BB, Selheim F, Wang J, Sakariassen PØ, Sandal T, Lønning PE, Flatmark T, Enger PØ, Bjerkvig R, Sioud M, Stallcup WB (2008)
    The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
    Oncogene, 27 (39), 5182-94
    PubMed 18469852
  4. Døsen-Dahl G, Munthe E, Nygren MK, Stubberud H, Hystad ME, Rian E (2008)
    Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFbeta/BMP-6 and TIEG1 in chemotherapy escape
    Int J Cancer, 123 (12), 2759-66
    PubMed 18798273
  5. Furset G, Fløisand Y, Sioud M (2008)
    Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands
    Immunology, 123 (2), 263-71
    PubMed 17725606
  6. Holen HL, Shadidi M, Narvhus K, Kjøsnes O, Tierens A, Aasheim HC (2008)
    Signaling through ephrin-A ligand leads to activation of Src-family kinases, Akt phosphorylation, and inhibition of antigen receptor-induced apoptosis
    J Leukoc Biol, 84 (4), 1183-91
    PubMed 18593733
  7. Kloster MM, Hafte TT, Moltzau LR, Naderi EH, Dahle MK, Skålhegg BS, Gaudernack G, Levy FO, Naderi S, Blomhoff HK (2008)
    EBV infection renders B cells resistant to growth inhibition via adenylyl cyclase
    Cell Signal, 20 (6), 1169-78
    PubMed 18406106
  8. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM (2008)
    Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
    Science, 319 (5870), 1676-9
    PubMed 18323416
  9. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G et al. (2008)
    Stromal gene signatures in large-B-cell lymphomas
    N Engl J Med, 359 (22), 2313-23
    PubMed 19038878
  10. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM (2008)
    Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
    Proc Natl Acad Sci U S A, 105 (36), 13520-5
    PubMed 18765795
  11. Maturana AD, Wälchli S, Iwata M, Ryser S, Van Lint J, Hoshijima M, Schlegel W, Ikeda Y, Tanizawa K, Kuroda S (2008)
    Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel
    Cardiovasc Res, 78 (3), 458-65
    PubMed 18296710
  12. O'Shea D, O'Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, Gribben J, Rosenwald A, Ott G, Rimsza LM, Smeland EB, Johnson N, Campo E, Greiner TC, Chan WC, Gascoyne RD, Wright G, Staudt LM, Lister TA, Fitzgibbon J (2008)
    The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
    Blood, 112 (8), 3126-9
    PubMed 18628487
  13. Oksvold MP, Dagger SA, Thien CB, Langdon WY (2008)
    The Cbl-b RING finger domain has a limited role in regulating inflammatory cytokine production by IgE-activated mast cells
    Mol Immunol, 45 (4), 925-36
    PubMed 17868870
  14. Shadidi M, Sørensen D, Dybwad A, Furset G, Sioud M (2008)
    Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma
    Int J Oncol, 32 (1), 241-7
    PubMed 18097564
  15. Sioud M (2008)
    Does the understanding of immune activation by RNA predict the design of safe siRNAs?
    Front Biosci, 13, 4379-92
    PubMed 18508517
  16. Sioud M, Cekaite L (2008)
    Expression profiling of microRNAs in cancer cells: technical considerations
    Methods Mol Biol, 439, 179-90
    PubMed 18370103
  17. Sørensen V, Zhen Y, Zakrzewska M, Haugsten EM, Wälchli S, Nilsen T, Olsnes S, Wiedlocha A (2008)
    Phosphorylation of fibroblast growth factor (FGF) receptor 1 at Ser777 by p38 mitogen-activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus
    Mol Cell Biol, 28 (12), 4129-41
    PubMed 18411303
  18. Walchli S, Sioud M (2008)
    Vector-based delivery of siRNAs: in vitro and in vivo challenges
    Front Biosci, 13, 3488-93
    PubMed 18508450
  19. Wester T, Jørgensen JJ, Stranden E, Sandbaek G, Tjønnfjord G, Bay D, Kollerøs D, Kroese AJ, Brinchmann JE (2008)
    Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study
    Scand J Surg, 97 (1), 56-62
    PubMed 18450207
  20. Wierød L, Rosseland CM, Lindeman B, Oksvold MP, Grøsvik H, Skarpen E, Huitfeldt HS (2008)
    Activation of the p53-p21(Cip1) pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes
    Oncogene, 27 (19), 2763-71
    PubMed 18026139

Publications 2007

  1. Aharinejad S, Sioud M, Lucas T, Abraham D (2007)
    Target validation using RNA interference in solid tumors
    Methods Mol Biol, 361, 227-38
    PubMed 17172715
  2. Borresen P, Taraldsrud E, Berentsen SA (2007)
    [A three-year-old boy with bullous skin eruptions and paresis]
    Tidsskr Nor Laegeforen, 127 (15), 1950-2
    PubMed 17708060
  3. Cabezón T, Celis JE, Skibshøj I, Klingelhöfer J, Grigorian M, Gromov P, Rank F, Myklebust JH, Maelandsmo GM, Lukanidin E, Ambartsumian N (2007)
    Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer
    Int J Cancer, 121 (7), 1433-44
    PubMed 17565747
  4. Cekaite L, Furset G, Hovig E, Sioud M (2007)
    Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects
    J Mol Biol, 365 (1), 90-108
    PubMed 17054988
  5. Cekaite L, Hovig E, Sioud M (2007)
    Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses
    Methods Mol Biol, 360, 335-48
    PubMed 17172738
  6. Ekstrøm PO, Bjørheim J, Thilly WG (2007)
    Technology to accelerate pangenomic scanning for unknown point mutations in exonic sequences: cycling temperature capillary electrophoresis (CTCE)
    BMC Genet, 8, 54
    PubMed 17697348
  7. Ertesvag A, Aasheim HC, Naderi S, Blomhoff HK (2007)
    Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK
    Blood, 109 (9), 3865-72
    PubMed 17209053
  8. Furset G, Sioud M (2007)
    Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule
    Biochem Biophys Res Commun, 352 (3), 642-9
    PubMed 17150189
  9. Hauge H, Patzke S, Aasheim HC (2007)
    Characterization of the FAM110 gene family
    Genomics, 90 (1), 14-27
    PubMed 17499476
  10. Hjorthaug HS, Aasheim HC (2007)
    Ephrin-A1 stimulates migration of CD8+CCR7+ T lymphocytes
    Eur J Immunol, 37 (8), 2326-36
    PubMed 17634955
  11. Hystad ME, Myklebust JH, Bø TH, Sivertsen EA, Rian E, Forfang L, Munthe E, Rosenwald A, Chiorazzi M, Jonassen I, Staudt LM, Smeland EB (2007)
    Characterization of early stages of human B cell development by gene expression profiling
    J Immunol, 179 (6), 3662-71
    PubMed 17785802
  12. Jarnjak-Jankovic S, Hammerstad H, Saebøe-Larssen S, Kvalheim G, Gaudernack G (2007)
    A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
    BMC Cancer, 7, 119
    PubMed 17608923
  13. Jarnjak-Jankovic S, Saebøe-Larssen S, Kvalheim G, Gaudernack G (2007)
    mRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNA
    Cytotherapy, 9 (6), 587-92
    PubMed 17882723
  14. Kyte JA, Kvalheim G, Lislerud K, thor Straten P, Dueland S, Aamdal S, Gaudernack G (2007)
    T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
    Cancer Immunol Immunother, 56 (5), 659-75
    PubMed 16947019
  15. Lehne G, Bjørheim J, Saeter G (2007)
    [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?]
    Tidsskr Nor Laegeforen, 127 (8), 1040-4
    PubMed 17457389
  16. Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM (2007)
    Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma
    J Exp Med, 204 (3), 633-43
    PubMed 17353367
  17. Nygren MK, Døsen G, Hystad ME, Stubberud H, Funderud S, Rian E (2007)
    Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines
    Br J Haematol, 136 (3), 400-13
    PubMed 17156404
  18. Røsok Ø, Sioud M (2007)
    Discovery of differentially expressed genes: technical considerations
    Methods Mol Biol, 360, 115-29
    PubMed 17172727
  19. Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E (2007)
    Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
    J Clin Oncol, 25 (10), 1216-22
    PubMed 17296973
  20. Sioud M (2007)
    RNA interference and innate immunity
    Adv Drug Deliv Rev, 59 (2-3), 153-63
    PubMed 17459518
  21. Sioud M (2007)
    An overview of the immune system and technical advances in tumor antigen discovery and validation
    Methods Mol Biol, 360, 277-318
    PubMed 17172735
  22. Sioud M (2007)
    Main approaches to target discovery and validation
    Methods Mol Biol, 360, 1-12
    PubMed 17172722
  23. Sioud M, Fløisand Y (2007)
    TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
    Eur J Immunol, 37 (10), 2834-46
    PubMed 17853407
  24. Sioud M, Furset G, Cekaite L (2007)
    Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs
    Biochem Biophys Res Commun, 361 (1), 122-6
    PubMed 17658482
  25. Sioud M, Leirdal M (2007)
    Druggable signaling proteins
    Methods Mol Biol, 361, 1-24
    PubMed 17172705
  26. Sioud M, Melien O (2007)
    Treatment options and individualized medicine
    Methods Mol Biol, 361, 327-40
    PubMed 17172721
  27. Sivertsen EA, Huse K, Hystad ME, Kersten C, Smeland EB, Myklebust JH (2007)
    Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells
    Eur J Immunol, 37 (10), 2937-48
    PubMed 17899540
  28. Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI et al. (2007)
    Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
    Blood, 109 (11), 4599-606
    PubMed 17299095
  29. Zins K, Abraham D, Sioud M, Aharinejad S (2007)
    Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway
    Cancer Res, 67 (3), 1038-45
    PubMed 17283136
  30. Aamot HV, Torlakovic EE, Eide MB, Holte H, Heim S (2007)
    Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations
    J Cancer Res Clin Oncol, 133 (7), 455-70
    PubMed 17235551

Publications 2006

  1. Angell-Petersen E, Spetalen S, Madsen SJ, Sun CH, Peng Q, Carper SW, Sioud M, Hirschberg H (2006)
    Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model
    J Neurosurg, 104 (1), 109-17
    PubMed 16509154
  2. Bernhardt SL, Gjertsen MK, Trachsel S, Møller M, Eriksen JA, Meo M, Buanes T, Gaudernack G (2006)
    Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study
    Br J Cancer, 95 (11), 1474-82
    PubMed 17060934
  3. Bjørheim J, Frich JC, Gjersvik P, Jacobsen G, Swensen E (2006)
    [Tidsskriftet, peer review and medical publishing]
    Tidsskr Nor Laegeforen, 126 (1), 20-3
    PubMed 16397649
  4. Borowiec A, Lechward K, Tkacz-Stachowska K, Sk?adanowski AC (2006)
    Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5'-nucleotidases
    Acta Biochim Pol, 53 (2), 269-78
    PubMed 16770441
  5. Brunsvig PF, Aamdal S, Gjertsen MK, Kvalheim G, Markowski-Grimsrud CJ, Sve I, Dyrhaug M, Trachsel S, Møller M, Eriksen JA, Gaudernack G (2006)
    Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
    Cancer Immunol Immunother, 55 (12), 1553-64
    PubMed 16491401
  6. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB et al. (2006)
    Molecular diagnosis of Burkitt's lymphoma
    N Engl J Med, 354 (23), 2431-42
    PubMed 16760443
  7. Døsen G, Tenstad E, Nygren MK, Stubberud H, Funderud S, Rian E (2006)
    Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis
    BMC Immunol, 7, 13
    PubMed 16808837
  8. Ekstrøm PO, Bjørheim J (2006)
    Evaluation of sieving matrices used to separate alleles by cycling temperature capillary electrophoresis
    Electrophoresis, 27 (10), 1878-85
    PubMed 16619298
  9. Gaudernack G (2006)
    Prospects for vaccine therapy for pancreatic cancer
    Best Pract Res Clin Gastroenterol, 20 (2), 299-314
    PubMed 16549329
  10. Huynh T, Wälchli S, Sioud M (2006)
    Transcriptional targeting of small interfering RNAs into cancer cells
    Biochem Biophys Res Commun, 350 (4), 854-9
    PubMed 17034763
  11. Ji Z, Yang G, Shahzidi S, Tkacz-Stachowska K, Suo Z, Nesland JM, Peng Q (2006)
    Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy
    Cancer Lett, 244 (2), 182-9
    PubMed 16427735
  12. Kersten C, Dosen G, Myklebust JH, Sivertsen EA, Hystad ME, Smeland EB, Rian E (2006)
    BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3
    Exp Hematol, 34 (1), 72-81
    PubMed 16413393
  13. Kyte JA (2006)
    [Cancer vaccines]
    Tidsskr Nor Laegeforen, 126 (22), 2969-73
    PubMed 17117197
  14. Kyte JA, Gaudernack G (2006)
    Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
    Cancer Immunol Immunother, 55 (11), 1432-42
    PubMed 16612595
  15. Kyte JA, Mu L, Aamdal S, Kvalheim G, Dueland S, Hauser M, Gullestad HP, Ryder T, Lislerud K, Hammerstad H, Gaudernack G (2006)
    Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
    Cancer Gene Ther, 13 (10), 905-18
    PubMed 16710345
  16. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006)
    Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction
    N Engl J Med, 355 (12), 1199-209
    PubMed 16990383
  17. Patzke S, Stokke T, Aasheim HC (2006)
    CSPP and CSPP-L associate with centrosomes and microtubules and differently affect microtubule organization
    J Cell Physiol, 209 (1), 199-210
    PubMed 16826565
  18. Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y (2006)
    DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
    Anticancer Res, 26 (3A), 1909-16
    PubMed 16827124
  19. Saebøe-Larssen S, Fossberg E, Gaudernack G (2006)
    Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues
    BMC Mol Biol, 7, 26
    PubMed 16939641
  20. Sioud M (2006)
    Ribozymes and siRnas: from structure to preclinical applications
    Handb Exp Pharmacol (173), 223-42
    PubMed 16594618
  21. Sioud M (2006)
    Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses
    Eur J Immunol, 36 (5), 1222-30
    PubMed 16609928
  22. Sioud M (2006)
    RNA interference below the immune radar
    Nat Biotechnol, 24 (5), 521-2
    PubMed 16680132
  23. Sioud M (2006)
    Innate sensing of self and non-self RNAs by Toll-like receptors
    Trends Mol Med, 12 (4), 167-76
    PubMed 16530484
  24. Sioud M (2006)
    RNAi therapy: antibodies guide the way
    Gene Ther, 13 (3), 194-5
    PubMed 17243203
  25. Sioud M, Fløisand Y, Forfang L, Lund-Johansen F (2006)
    Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage
    J Mol Biol, 364 (5), 945-54
    PubMed 17049554
  26. Sioud M, Furset G (2006)
    Molecular basis for the immunostimulatory potency of small interfering RNAs
    J Biomed Biotechnol, 2006 (4), 23429
    PubMed 17057361
  27. Sioud M, Haoudi A (2006)
    RNA interference
    J Biomed Biotechnol, 2006 (4), 89018
    PubMed 17057373
  28. Sivertsen EA, Galteland E, Mu D, Holte H, Meza-Zepeda L, Myklebost O, Patzke S, Smeland EB, Stokke T (2006)
    Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas
    Leukemia, 20 (3), 539-42
    PubMed 16437153
  29. Sivertsen EA, Hystad ME, Gutzkow KB, Døsen G, Smeland EB, Blomhoff HK, Myklebust JH (2006)
    PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells
    Br J Haematol, 135 (1), 117-28
    PubMed 16965383
  30. Thomassen GO, Røsok O, Rognes T (2006)
    Computational prediction of microRNAs encoded in viral and other genomes
    J Biomed Biotechnol, 2006 (4), 95270
    PubMed 17057374
  31. Winning J, Claus RA, Huse K, Bauer M (2006)
    Molecular biology on the ICU. From understanding to treating sepsis
    Minerva Anestesiol, 72 (5), 255-67
    PubMed 16675935
  32. Zheng W, Rosenstiel P, Huse K, Sina C, Valentonyte R, Mah N, Zeitlmann L, Grosse J, Ruf N, Nürnberg P, Costello CM, Onnie C, Mathew C, Platzer M, Schreiber S, Hampe J (2006)
    Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease
    Genes Immun, 7 (1), 11-8
    PubMed 16222343

Publications 2005

  1. Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R et al. (2005)
    Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
    Blood, 106 (9), 3183-90
    PubMed 16046532
  2. Bjørheim J (2005)
    [Diagnostic mosaic]
    Tidsskr Nor Laegeforen, 125 (21), 2916
    PubMed 16276367
  3. Bjørheim J, Ekstrøm PO (2005)
    Review of denaturant capillary electrophoresis in DNA variation analysis
    Electrophoresis, 26 (13), 2520-30
    PubMed 15934053
  4. Furre IE, Shahzidi S, Luksiene Z, Møller MT, Borgen E, Morgan J, Tkacz-Stachowska K, Nesland JM, Peng Q (2005)
    Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells
    Cancer Res, 65 (23), 11051-60
    PubMed 16322255
  5. Galteland E, Sivertsen EA, Svendsrud DH, Smedshammer L, Kresse SH, Meza-Zepeda LA, Myklebost O, Suo Z, Mu D, Deangelis PM, Stokke T (2005)
    Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas
    Leukemia, 19 (12), 2313-23
    PubMed 16193090
  6. Jarnjak-Jankovic S, Pettersen RD, Saebøe-Larssen S, Wesenberg F, Gaudernack G (2005)
    Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia
    BMC Cancer, 5, 20
    PubMed 15720715
  7. Jarnjak-Jankovic S, Pettersen RD, Saebøe-Larssen S, Wesenberg F, Olafsen MR, Gaudernack G (2005)
    Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma
    Cancer Gene Ther, 12 (8), 699-707
    PubMed 15846368
  8. Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH (2005)
    BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1
    BMC Immunol, 6, 9
    PubMed 15877825
  9. Kyte JA, Kvalheim G, Aamdal S, Saebøe-Larssen S, Gaudernack G (2005)
    Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination
    Cancer Gene Ther, 12 (6), 579-91
    PubMed 15818380
  10. Moche M, Hui DS, Huse K, Chan KS, Choy DK, Scholz GH, Gosse H, Winkler J, Schauer J, Sack U, Hoheisel G (2005)
    [Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
    Pneumologie, 59 (8), 523-8
    PubMed 16110415
  11. Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, Hammerstad H, Waehre H, Raabe N, Gaudernack G (2005)
    Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
    Br J Cancer, 93 (7), 749-56
    PubMed 16136047
  12. Patzke S, Hauge H, Sioud M, Finne EF, Sivertsen EA, Delabie J, Stokke T, Aasheim HC (2005)
    Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization
    Oncogene, 24 (7), 1159-73
    PubMed 15580290
  13. Røsok O, Sioud M (2005)
    Systematic search for natural antisense transcripts in eukaryotes (review)
    Int J Mol Med, 15 (2), 197-203
    PubMed 15647831
  14. Sioud M (2005)
    On the delivery of small interfering RNAs into mammalian cells
    Expert Opin Drug Deliv, 2 (4), 639-51
    PubMed 16296791
  15. Sioud M (2005)
    siRNA delivery in vivo
    Methods Mol Biol, 309, 237-49
    PubMed 15990404
  16. Sioud M (2005)
    Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization
    J Mol Biol, 348 (5), 1079-90
    PubMed 15854645
  17. Sioud M, Iversen PO (2005)
    Ribozymes, DNAzymes and small interfering RNAs as therapeutics
    Curr Drug Targets, 6 (6), 647-53
    PubMed 16178798
  18. Sioud M, Røsok Ø (2005)
    High-throughput analysis of microRNA gene expression using sensitive probes
    Methods Mol Biol, 309, 311-20
    PubMed 15990410
  19. Sioud M, Wälchli S (2005)
    Strategies for the design of random siRNA libraries and the selection of anti-GFP siRNAs
    Methods Mol Biol, 309, 83-91
    PubMed 15990399
  20. Tkacz-Stachowska K, Lechward K, Skladanowski AC (2005)
    Isolation and characterization of pigeon breast muscle cytosolic 5'-nucleotidase-I (cN-I)
    Acta Biochim Pol, 52 (4), 789-96
    PubMed 15940349
  21. Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J (2005)
    PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor
    J Pathol, 206 (3), 312-9
    PubMed 15892171
  22. Torlakovic E, Tenstad E, Funderud S, Rian E (2005)
    CD10+ stromal cells form B-lymphocyte maturation niches in the human bone marrow
    J Pathol, 205 (3), 311-7
    PubMed 15682430
  23. Aasheim HC, Delabie J, Finne EF (2005)
    Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2
    Blood, 105 (7), 2869-76
    PubMed 15585656
  24. Aasheim HC, Patzke S, Hjorthaug HS, Finne EF (2005)
    Characterization of a novel Eph receptor tyrosine kinase, EphA10, expressed in testis
    Biochim Biophys Acta, 1723 (1-3), 1-7
    PubMed 15777695

Publications 2004

  1. Aharinejad S, Paulus P, Sioud M, Hofmann M, Zins K, Schäfer R, Stanley ER, Abraham D (2004)
    Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
    Cancer Res, 64 (15), 5378-84
    PubMed 15289345
  2. Breivik J, Gaudernack G (2004)
    Resolving the evolutionary paradox of genetic instability: a cost-benefit analysis of DNA repair in changing environments
    FEBS Lett, 563 (1-3), 7-12
    PubMed 15063714
  3. Cekaite L, Haug O, Myklebost O, Aldrin M, Østenstad B, Holden M, Frigessi A, Hovig E, Sioud M (2004)
    Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method
    Proteomics, 4 (9), 2572-82
    PubMed 15352232
  4. Dai KZ, Johansen FE, Kolltveit KM, Aasheim HC, Dembic Z, Vartdal F, Spurkland A (2004)
    Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5'-monophosphate-responsive element in the proximal SH2D2A promoter
    J Immunol, 172 (10), 6144-51
    PubMed 15128801
  5. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA et al. (2004)
    Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
    N Engl J Med, 351 (21), 2159-69
    PubMed 15548776
  6. Elahi EN, Wright Z, Hinselwood D, Hotchkiss SA, Basketter DA, Pease CK (2004)
    Protein binding and metabolism influence the relative skin sensitization potential of cinnamic compounds
    Chem Res Toxicol, 17 (3), 301-10
    PubMed 15025500
  7. Finne EF, Munthe E, Aasheim HC (2004)
    A new ephrin-A1 isoform (ephrin-A1b) with altered receptor binding properties abrogates the cleavage of ephrin-A1a
    Biochem J, 379 (Pt 1), 39-46
    PubMed 14692877
  8. Fosså A, Alsøe L, Crameri R, Funderud S, Gaudernack G, Smeland EB (2004)
    Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display
    Cancer Immunol Immunother, 53 (5), 431-8
    PubMed 14747957
  9. Fosså A, Berner A, Fosså SD, Hernes E, Gaudernack G, Smeland EB (2004)
    NY-ESO-1 protein expression and humoral immune responses in prostate cancer
    Prostate, 59 (4), 440-7
    PubMed 15065093
  10. Hauge H, Patzke S, Delabie J, Aasheim HC (2004)
    Characterization of a novel immunoglobulin-like domain containing receptor
    Biochem Biophys Res Commun, 323 (3), 970-8
    PubMed 15381095
  11. Hirschberg H, Madsen S, Angell-Petersen E, Peng Q, Sioud M, Sun CH, Sorensen DR (2004)
    Repetitive 5-aminolevulinic acid mediated photodynamic therapy of rat glioma
    P SOC PHOTO-OPT INS, 5312, 405-414
  12. Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, Aukrust P, Frøland SS (2004)
    Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells
    Clin Exp Immunol, 138 (2), 278-89
    PubMed 15498038
  13. Iversen PO, Sioud M (2004)
    Inhibition of gene expression by nucleic acid enzymes in rodent models of human disease
    Methods Mol Biol, 252, 451-6
    PubMed 15017070
  14. Kersten C, Delabie J, Gaudernack G, Smeland EB, Fosså A (2004)
    Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2
    Cancer Immunol Immunother, 53 (12), 1119-26
    PubMed 15185015
  15. Kristensen AT, Bjørheim J, Wiig J, Giercksky KE, Ekstrøm PO (2004)
    DNA variants in the ATM gene are not associated with sporadic rectal cancer in a Norwegian population-based study
    Int J Colorectal Dis, 19 (1), 49-54
    PubMed 12827413
  16. Lazarova P, Lijun M, Hammerstad H, Nesland J, Gaudernack G, Kvalheim G (2004)
    Experimental attempt to introduce a vaccine therapy by using DC-developed from CD34+cells
    NATO SCI SER I LIFE, 361, 134
  17. Leirdal M, Shadidy M, Røsok Ø, Sioud M (2004)
    Identification of genes differentially expressed in breast cancer cell line SKBR3: potential identification of new prognostic biomarkers
    Int J Mol Med, 14 (2), 217-22
    PubMed 15254768
  18. Leirdal M, Sioud M (2004)
    Gene-array analysis of glioma cells after treatment with an anti-PKCalpha siRNA: a general protocol
    Methods Mol Biol, 252, 493-500
    PubMed 15017074
  19. Lyngstadaas A, Husebekk A, Funderud S, Brinch L (2004)
    [Clinical use of haematopoietic stem cells from cord blood]
    Tidsskr Nor Laegeforen, 124 (22), 2928-31
    PubMed 15550970
  20. Mu LJ, Lazarova P, Gaudernack G, Saeboe-Larssen S, Kvalheim G (2004)
    Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells
    Int J Immunopathol Pharmacol, 17 (3), 255-63
    PubMed 15461859
  21. Munthe E, Finne EF, Aasheim HC (2004)
    Expression and functional effects of Eph receptor tyrosine kinase A family members on Langerhans like dendritic cells
    BMC Immunol, 5, 9
    PubMed 15176971
  22. Reppe S, Olstad OK, Rian E, Gautvik VT, Gautvik KM, Jemtland R (2004)
    Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells
    Biochem Biophys Res Commun, 324 (1), 218-23
    PubMed 15465005
  23. Røsok O, Sioud M (2004)
    An experimental approach for systematic identification of antisense transcripts
    Discov Med, 4 (20), 58-60
    PubMed 20705023
  24. Røsok Ø, Sioud M (2004)
    Systematic identification of sense-antisense transcripts in mammalian cells
    Nat Biotechnol, 22 (1), 104-8
    PubMed 14704709
  25. Shadidi M, Sioud M (2004)
    Selection of peptides for specific delivery of oligonucleotides into cancer cells
    Methods Mol Biol, 252, 569-80
    PubMed 15017081
  26. Sinnreich O, Kratzsch J, Reichenbach A, Gläser C, Huse K, Birkenmeier G (2004)
    Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters
    Prostate, 61 (3), 201-8
    PubMed 15368477
  27. Sioud M (2004)
    Therapeutic potential of small interfering RNAs
    Drug Future, 29 (7), 741-750
  28. Sioud M (2004)
    Therapeutic siRNAs
    Trends Pharmacol Sci, 25 (1), 22-8
    PubMed 14723975
  29. Sioud M (2004)
    Ribozyme- and siRNA-mediated mRNA degradation: a general introduction
    Methods Mol Biol, 252, 1-8
    PubMed 15017038
  30. Sioud M, Leirdal M (2004)
    Potential design rules and enzymatic synthesis of siRNAs
    Methods Mol Biol, 252, 457-69
    PubMed 15017071
  31. Sioud M, Røsok O (2004)
    Profiling microRNA expression using sensitive cDNA probes and filter arrays
    Biotechniques, 37 (4), 574-6, 578-80
    PubMed 15517969
  32. Sioud M, Sørensen DR (2004)
    Systemic delivery of synthetic siRNAs
    Methods Mol Biol, 252, 515-22
    PubMed 15017077
  33. Sivertsen EA, Torfoss D (2004)
    [Cryptococcal meningitis]
    Tidsskr Nor Laegeforen, 124 (1), 28-30
    PubMed 14716388

Publications 2003

  1. Birkenmeier G, Müller R, Huse K, Forberg J, Gläser C, Hedrich H, Nicklisch S, Reichenbach A (2003)
    Human alpha2-macroglobulin: genotype-phenotype relation
    Exp Neurol, 184 (1), 153-61
    PubMed 14637088
  2. Bjorheim J, Minarik M, Gaudernack G, Ekstrom PO (2003)
    Evaluation of denaturing conditions in analysis of DNA variants applied to multi-capillary electrophoresis instruments
    J. Sep. Sci., 26 (12-13), 1163-1168
  3. Bjørheim J, Abrahamsen TW, Kristensen AT, Gaudernack G, Ekstrøm PO (2003)
    Approach to analysis of single nucleotide polymorphisms by automated constant denaturant capillary electrophoresis
    Mutat Res, 526 (1-2), 75-83
    PubMed 12714185
  4. Bjørheim J, Gaudernack G, Giercksky KE, Ekstrøm PO (2003)
    Direct identification of all oncogenic mutants in KRAS exon 1 by cycling temperature capillary electrophoresis
    Electrophoresis, 24 (1-2), 63-9
    PubMed 12652573
  5. Bønsdorff T, Eggen A, Gautier M, Asheim HC, Rønningen K, Lingaas F, Olsaker I (2003)
    Identification and physical mapping of genes expressed in the corpus luteum in cattle
    Anim Genet, 34 (5), 325-33
    PubMed 14510667
  6. Dybwad A, Lambin P, Sioud M, Zouali M (2003)
    Probing the specificity of human myeloma proteins with a random peptide phage library
    Scand J Immunol, 57 (6), 583-90
    PubMed 12791097
  7. Gjertsen MK, Saeterdal I, Saebøe-Larssen S, Gaudernack G (2003)
    HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes
    J Mol Med (Berl), 81 (1), 43-50
    PubMed 12545248
  8. Minarik M, Minarikova L, Bjørheim J, Ekstrøm PO (2003)
    Cycling gradient capillary electrophoresis: a low-cost tool for high-throughput analysis of genetic variations
    Electrophoresis, 24 (11), 1716-22
    PubMed 12783447
  9. Mu LJ, Gaudernack G, Saebøe-Larssen S, Hammerstad H, Tierens A, Kvalheim G (2003)
    A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines
    Scand J Immunol, 58 (5), 578-86
    PubMed 14629630
  10. Olstad OK, Gautvik VT, Reppe S, Rian E, Jemtland R, Ohlsson C, Bruland OS, Gautvik KM (2003)
    Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning
    Anticancer Res, 23 (3B), 2201-16
    PubMed 12894494
  11. Paus E, Almåsbak H, Børmer OP, Warren DJ (2003)
    A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2
    J Immunol Methods, 283 (1-2), 125-39
    PubMed 14659905
  12. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R et al. (2003)
    Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
    J Exp Med, 198 (6), 851-62
    PubMed 12975453
  13. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC et al. (2003)
    The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
    Cancer Cell, 3 (2), 185-97
    PubMed 12620412
  14. Shadidi M, Sioud M (2003)
    Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells
    FASEB J, 17 (2), 256-8
    PubMed 12490548
  15. Shadidi M, Sioud M (2003)
    Selective targeting of cancer cells using synthetic peptides
    Drug Resist Updat, 6 (6), 363-71
    PubMed 14744500
  16. Sioud M, Sørensen D (2003)
    Generation of an effective anti-tumor immunity after immunization with xenogeneic antigens
    Eur J Immunol, 33 (1), 38-45
    PubMed 12594830
  17. Sioud M, Sørensen DR (2003)
    Cationic liposome-mediated delivery of siRNAs in adult mice
    Biochem Biophys Res Commun, 312 (4), 1220-5
    PubMed 14652004
  18. Stacy JE, Kausmally L, Simonsen B, Nordgard SH, Alsøe L, Michaelsen TE, Brekke OH (2003)
    Direct isolation of recombinant human antibodies against group B Neisseria meningitidis from scFv expression libraries
    J Immunol Methods, 283 (1-2), 247-59
    PubMed 14659916
  19. Sørensen DR, Leirdal M, Sioud M (2003)
    Gene silencing by systemic delivery of synthetic siRNAs in adult mice
    J Mol Biol, 327 (4), 761-6
    PubMed 12654261
  20. Taraldsrud E, Kvalheim G, Jørstad S, Stavem K, Aandahl GS (2003)
    A survey of therapeutic hemapheresis in Norway year 2000
    Transfus Apher Sci, 28 (2), 135-41
    PubMed 12679117
  21. Taraldsrud E, Aandahl GS, Stavem K, Kvalheim G, Jørstad S (2003)
    [Therapeutic hemapheresis]
    Tidsskr Nor Laegeforen, 123 (17), 2439-42
    PubMed 14594145
  22. Wabakken T, Rian E, Kveine M, Aasheim HC (2003)
    The human solute carrier SLC41A1 belongs to a novel eukaryotic subfamily with homology to prokaryotic MgtE Mg2+ transporters
    Biochem Biophys Res Commun, 306 (3), 718-24
    PubMed 12810078

Publications 2002

  1. Bjorheim J, Gaudernack G, Ekstrom PO (2002)
    Melting gel techniques in single nucleotide polymorphism and mutation detection: From theory to automation
    J. Sep. Sci., 25 (10-11), 637-647
  2. Bjørheim J, Minarik M, Gaudernack G, Ekstrøm PO (2002)
    Mutation detection in KRAS Exon 1 by constant denaturant capillary electrophoresis in 96 parallel capillaries
    Anal Biochem, 304 (2), 200-5
    PubMed 12009696
  3. Ekstrøm PO, Bjørheim J (2002)
    Reducing the cost of consumables used for ABI 310 genetic analyzer
    Anal Biochem, 306 (1), 148-9
    PubMed 12069426
  4. Ekstrøm PO, Bjørheim J, Gaudernack G, Giercksky KE (2002)
    Population screening of single-nucleotide polymorphisms exemplified by analysis of 8000 alleles
    J Biomol Screen, 7 (6), 501-6
    PubMed 14599347
  5. Fosså A, Lilleby W, Fosså SD, Gaudernack G, Torlakovic G, Berner A (2002)
    Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy
    Int J Cancer, 99 (1), 100-5
    PubMed 11948499
  6. Iversen PO, Emanuel PD, Sioud M (2002)
    Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth
    Blood, 99 (11), 4147-53
    PubMed 12010819
  7. Kristensen AT, Bjørheim J, Ekstrøm PO (2002)
    Detection of mutations in exon 8 of TP53 by temperature gradient 96-capillary array electrophoresis
    Biotechniques, 33 (3), 650-3
    PubMed 12238774
  8. Kveine M, Tenstad E, Døsen G, Funderud S, Rian E (2002)
    Characterization of the novel human transmembrane protein 9 (TMEM9) that localizes to lysosomes and late endosomes
    Biochem Biophys Res Commun, 297 (4), 912-7
    PubMed 12359240
  9. Leirdal M, Sioud M (2002)
    [Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic tarfet in cancer]
    Tidsskr Nor Laegeforen, 122 (2), 178-82
    PubMed 11873574
  10. Leirdal M, Sioud M (2002)
    Gene silencing in mammalian cells by preformed small RNA duplexes
    Biochem Biophys Res Commun, 295 (3), 744-8
    PubMed 12099702
  11. Lundqvist A, Noffz G, Pavlenko M, Saebøe-Larssen S, Fong T, Maitland N, Pisa P (2002)
    Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection
    J Immunother, 25 (6), 445-54
    PubMed 12439342
  12. Machon O, van den Bout CJ, Backman M, Røsok Ø, Caubit X, Fromm SH, Geronimo B, Krauss S (2002)
    Forebrain-specific promoter/enhancer D6 derived from the mouse Dach1 gene controls expression in neural stem cells
    Neuroscience, 112 (4), 951-66
    PubMed 12088753
  13. Munthe E, Aasheim HC (2002)
    Characterization of the human ephrin-A4 promoter
    Biochem J, 366 (Pt 2), 447-58
    PubMed 12030849
  14. Myklebust JH, Blomhoff HK, Rusten LS, Stokke T, Smeland EB (2002)
    Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells
    Exp Hematol, 30 (9), 990-1000
    PubMed 12225790
  15. Patzke S, Lindeskog M, Munthe E, Aasheim HC (2002)
    Characterization of a novel human endogenous retrovirus, HERV-H/F, expressed in human leukemia cell lines
    Virology, 303 (1), 164-73
    PubMed 12482668
  16. Paulsen JE, Bjørheim J, Røe J, Eide TJ, Alexander J, Gaudernack G (2002)
    Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane
    Anticancer Res, 22 (1A), 171-5
    PubMed 12017282
  17. Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
    Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
    Anticancer Res, 22 (4), 1949-57
    PubMed 12174869
  18. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ et al. (2002)
    The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
    N Engl J Med, 346 (25), 1937-47
    PubMed 12075054
  19. Saebøe-Larssen S, Fossberg E, Gaudernack G (2002)
    mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)
    J Immunol Methods, 259 (1-2), 191-203
    PubMed 11730854
  20. Sioud M (2002)
    How does autoimmunity cause tumor regression? A potential mechanism involving cross-reaction through epitope mimicry
    Mol Med, 8 (3), 115-9
    PubMed 12142543
  21. Sorensen DR, Leirdal M, Iversen PO, Sioud M (2002)
    Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma
    Neoplasia, 4 (6), 474-9
    PubMed 12407440
  22. van den Bout CJ, Machon O, Røsok Ø, Backman M, Krauss S (2002)
    The mouse enhancer element D6 directs Cre recombinase activity in the neocortex and the hippocampus
    Mech Dev, 110 (1-2), 179-82
    PubMed 11744379
  23. Wabakken T, Hauge H, Finne EF, Wiedlocha A, Aasheim H (2002)
    Expression of human protein tyrosine phosphatase epsilon in leucocytes: a potential ERK pathway-regulating phosphatase
    Scand J Immunol, 56 (2), 195-203
    PubMed 12121439
  24. Wabakken T, Hauge H, Funderud S, Aasheim HC (2002)
    Characterization, expression and functional aspects of a novel protein tyrosine phosphatase epsilon isoform
    Scand J Immunol, 56 (3), 276-85
    PubMed 12193229
  25. Wang J, Delabie J, Aasheim H, Smeland E, Myklebost O (2002)
    Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study
    BMC Bioinformatics, 3, 36
    PubMed 12445336

Publications 2001

  1. Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N, Beranek M, Jandik P, Benamouzig R, Jullian E, Laurent-Puig P, Olschwang S, Muller O, Hoffmann I, Rabes HM, Zietz C, Troungos C, Valavanis C, Yuen ST, Ho JW, Croke CT et al. (2001)
    Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study
    Br J Cancer, 85 (5), 692-6
    PubMed 11531254
  2. Bethge N, Vakil N (2001)
    A prospective trial of a new self-expanding plastic stent for malignant esophageal obstruction
    Am J Gastroenterol, 96 (5), 1350-4
    PubMed 11374667
  3. Bjørheim J, Ekstrøm PO, Fossberg E, Børresen-Dale AL, Gaudernack G (2001)
    Automated constant denaturant capillary electrophoresis applied for detection of KRAS exon 1 mutations
    Biotechniques, 30 (5), 972-5
    PubMed 11355359
  4. Bjørheim J, Gaudernack G, Ekstrøm PO (2001)
    Mutation analysis of TP53 exons 5-8 by automated constant denaturant capillary electrophoresis
    Tumour Biol, 22 (5), 323-7
    PubMed 11553863
  5. Blystad AK, Holte H, Kvaløy S, Smeland E, Delabie J, Kvalheim G (2001)
    High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells
    Bone Marrow Transplant, 28 (9), 849-57
    PubMed 11781645
  6. Borge OJ, Funderud S (2001)
    [Stem cells in adults]
    Tidsskr Nor Laegeforen, 121 (20), 2398-401
    PubMed 11603050
  7. Breivik J (2001)
    Don't stop for repairs in a war zone: Darwinian evolution unites genes and environment in cancer development
    Proc Natl Acad Sci U S A, 98 (10), 5379-81
    PubMed 11344279
  8. Gjertsen MK, Buanes T, Rosseland AR, Bakka A, Gladhaug I, Søreide O, Eriksen JA, Møller M, Baksaas I, Lothe RA, Saeterdal I, Gaudernack G (2001)
    Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma
    Int J Cancer, 92 (3), 441-50
    PubMed 11291084
  9. Hansen MH, Ostenstad B, Sioud M (2001)
    Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour
    Int J Oncol, 19 (6), 1303-9
    PubMed 11713604
  10. Hansen MH, Ostenstad B, Sioud M (2001)
    Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients
    Mol Med, 7 (4), 230-9
    PubMed 11471567
  11. Hauge H (2001)
    [Future specialists between education and competence]
    Ugeskr Laeger, 163 (51), 7262-4
    PubMed 11797559
  12. Hoheisel G, Sack U, Hui DS, Huse K, Chan KS, Chan KK, Hartwig K, Schuster E, Scholz GH, Schauer J (2001)
    Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis
    Tuberculosis (Edinb), 81 (3), 203-9
    PubMed 11466032
  13. Hovig E, Myklebost O, Aamdal S, Smeland EB (2001)
    [Gene therapy in cancer]
    Tidsskr Nor Laegeforen, 121 (4), 482-8
    PubMed 11255868
  14. Hunger RE, Brand CU, Streit M, Eriksen JA, Gjertsen MK, Saeterdal I, Braathen LR, Gaudernack G (2001)
    Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant
    Exp Dermatol, 10 (3), 161-7
    PubMed 11380611
  15. Iversen PO, Nicolaysen G, Sioud M (2001)
    DNA enzyme targeting TNF-alpha mRNA improves hemodynamic performance in rats with postinfarction heart failure
    Am J Physiol Heart Circ Physiol, 281 (5), H2211-7
    PubMed 11668085
  16. Lyngstadaas A, Smeland EB (2001)
    [Gene therapy--status and recommendations in Norwegian health care system]
    Tidsskr Nor Laegeforen, 121 (3), 343-8
    PubMed 11242880
  17. Melien O, Christoffersen T, Sioud M (2001)
    Evidence for the involvement of G(i2) in activation of extracellular signal-regulated kinases in hepatocytes
    BMC Cell Biol., 2, art. no.-13
  18. Melien O, Christoffersen T, Sioud M (2001)
    Evidence for the involvement of Gi2 in activation of extracellular signal-regulated kinases in hepatocytes
    BMC Cell Biol, 2, 13
    PubMed 11495629
  19. Nørgaard P, Westphal V, Tachibana C, Alsøe L, Holst B, Winther JR (2001)
    Functional differences in yeast protein disulfide isomerases
    J Cell Biol, 152 (3), 553-62
    PubMed 11157982
  20. Rian E, Wabakken T, Hauge H, Aasheim HC (2001)
    A signal sequence trap based on cell enrichment using anti-CD19 antibody coated magnetic beads
    Scand J Immunol, 54 (3), 280-4
    PubMed 11555391
  21. Saeterdal I, Bjørheim J, Lislerud K, Gjertsen MK, Bukholm IK, Olsen OC, Nesland JM, Eriksen JA, Møller M, Lindblom A, Gaudernack G (2001)
    Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
    Proc Natl Acad Sci U S A, 98 (23), 13255-60
    PubMed 11687624
  22. Saeterdal I, Gjertsen MK, Straten P, Eriksen JA, Gaudernack G (2001)
    A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells
    Cancer Immunol Immunother, 50 (9), 469-76
    PubMed 11761441
  23. Shadidi M, Sioud M (2001)
    An anti-leukemic single chain Fv antibody selected from a synthetic human phage antibody library
    Biochem Biophys Res Commun, 280 (2), 548-52
    PubMed 11162553
  24. Sioud M (2001)
    Nucleic acid enzymes as a novel generation of anti-gene agents
    Curr Mol Med, 1 (5), 575-88
    PubMed 11899232
  25. Sioud M, Hansen MH (2001)
    Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries
    Eur J Immunol, 31 (3), 716-25
    PubMed 11241275
  26. Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB, Smeland EB, Delabie J, Holte H (2001)
    Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
    Br J Cancer, 85 (12), 1900-13
    PubMed 11747333
  27. Tölö H, Kauppinen HL, Alm G, Perers A, Lindeberg E, Wahlstedt-Fröberg V, Parkkinen J (2001)
    Development of a highly purified multicomponent leukocyte IFN-alpha product
    J Interferon Cytokine Res, 21 (11), 913-20
    PubMed 11747623
  28. Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, Zuccaro G, Bosco JJ, Jones WF (2001)
    A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction
    Am J Gastroenterol, 96 (6), 1791-6
    PubMed 11419831
  29. von Bonsdorff L, Tölö H, Lindeberg E, Nyman T, Harju A, Parkkinen J (2001)
    Development of a pharmaceutical apotransferrin product for iron binding therapy
    Biologicals, 29 (1), 27-37
    PubMed 11482890

Publications 2000

  1. Ertesvåg A, Blomhoff HK, Beiske K, Naderi S (2000)
    Co-induction of Mad1 and c-Myc in activated normal B lymphocytes
    Scand J Immunol, 51 (6), 565-70
    PubMed 10849366
  2. Fosså A, Siebert R, Aasheim HC, Maelandsmo GM, Berner A, Fosså SD, Paus E, Smeland EB, Gaudernack G (2000)
    Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
    Br J Cancer, 83 (6), 743-9
    PubMed 10952778
  3. Hansen MH, Dybwad A, Førre O, Sioud M (2000)
    Probing antinuclear antibody specificities by peptide phage display libraries
    Clin Exp Rheumatol, 18 (4), 465-72
    PubMed 10949721
  4. Josefsen D, Myklebust JH, Lømo J, Sioud M, Blomhoff HK, Smeland EB (2000)
    Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells
    Stem Cells, 18 (4), 261-72
    PubMed 10924092
  5. Leirdal M, Sioud M (2000)
    Protein kinase Calpha isoform regulates the activation of the MAP kinase ERK1/2 in human glioma cells: involvement in cell survival and gene expression
    Mol Cell Biol Res Commun, 4 (2), 106-10
    PubMed 11170840
  6. Munthe E, Rian E, Holien T, Rasmussen A, Levy FO, Aasheim H (2000)
    Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6
    FEBS Lett, 466 (1), 169-74
    PubMed 10648835
  7. Myklebust JH, Smeland EB, Josefsen D, Sioud M (2000)
    Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow
    Blood, 95 (2), 510-8
    PubMed 10627456
  8. Naderi S, Gützkow KB, Christoffersen J, Smeland EB, Blomhoff HK (2000)
    cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation
    Eur J Immunol, 30 (6), 1757-68
    PubMed 10898514
  9. Reppe S, Rian E, Jemtland R, Olstad OK, Gautvik VT, Gautvik KM (2000)
    Sox-4 messenger RNA is expressed in the embryonic growth plate and regulated via the parathyroid hormone/parathyroid hormone-related protein receptor in osteoblast-like cells
    J Bone Miner Res, 15 (12), 2402-12
    PubMed 11127205
  10. Røsok O, Pedeutour F, Odeberg J, Lundeberg J, Aasheim HC (2000)
    The C1orf9 gene encodes a putative transmembrane member of a novel protein family
    Biochem Biophys Res Commun, 267 (3), 855-62
    PubMed 10673381
  11. Sioud M, Hansen M, Dybwad A (2000)
    Profiling the immune responses in patient sera with peptide and cDNA display libraries
    Int J Mol Med, 6 (2), 123-8
    PubMed 10891554
  12. Sioud M, Leirdal M (2000)
    Design of nuclease resistant protein kinase calpha DNA enzymes with potential therapeutic application
    J Mol Biol, 296 (3), 937-47
    PubMed 10677293
  13. Sioud M, Leirdal M (2000)
    Therapeutic RNA and DNA enzymes
    Biochem Pharmacol, 60 (8), 1023-6
    PubMed 11007937
  14. Stokke T, Galteland E, Holte H, Smedshammer L, Suo Z, Smeland EB, Børresen-Dale AL, DeAngelis P, Steen HB (2000)
    Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma
    Int J Cancer, 89 (4), 313-24
    PubMed 10956404
  15. Aasheim HC, Munthe E, Funderud S, Smeland EB, Beiske K, Logtenberg T (2000)
    A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes
    Blood, 95 (1), 221-30
    PubMed 10607706
 
[1492 visits]
>> Go back   >> Print this page   >> E-mail this page